Krishnan Anand

4.8k total citations · 1 hit paper
125 papers, 3.5k citations indexed

About

Krishnan Anand is a scholar working on Molecular Biology, Cancer Research and Materials Chemistry. According to data from OpenAlex, Krishnan Anand has authored 125 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 19 papers in Cancer Research and 19 papers in Materials Chemistry. Recurrent topics in Krishnan Anand's work include Extracellular vesicles in disease (25 papers), Nanoparticles: synthesis and applications (16 papers) and MicroRNA in disease regulation (14 papers). Krishnan Anand is often cited by papers focused on Extracellular vesicles in disease (25 papers), Nanoparticles: synthesis and applications (16 papers) and MicroRNA in disease regulation (14 papers). Krishnan Anand collaborates with scholars based in South Africa, India and Australia. Krishnan Anand's co-authors include Anil A. Chuturgoon, Robert Moonsamy Gengan, Alisa Phulukdaree, Charlette Tiloke, Kamal Dua, Sachin Kumar Singh, Dinesh Kumar Chellappan, Muthupandian Saravanan, Gaurav Gupta and Monica Gulati and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Krishnan Anand

119 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics

2023 147 citations Rajib Dhar, Sagnik Nag et al. ACS Biomaterials Science & Engineering profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Krishnan Anand South Africa	32	1.3k	901	837	414	412	125	3.5k
Ali A. Alshatwi Saudi Arabia	39	1.1k 0.9×	1.1k 1.2×	671 0.8×	316 0.8×	704 1.7×	168	4.5k
Ahmed Abdal Dayem South Korea	25	1.4k 1.1×	1.2k 1.3×	1.3k 1.6×	202 0.5×	234 0.6×	58	4.1k
Majid S. Jabir Iraq	50	2.3k 1.8×	1.1k 1.2×	1.6k 1.9×	451 1.1×	381 0.9×	251	5.8k
Moganavelli Singh South Africa	35	1.1k 0.9×	1.1k 1.2×	796 1.0×	544 1.3×	441 1.1×	191	3.8k
Fars K. Alanazi Saudi Arabia	38	1.2k 1.0×	793 0.9×	520 0.6×	411 1.0×	247 0.6×	235	4.9k
Sandeep Kumar Dash India	29	1.2k 0.9×	517 0.6×	552 0.7×	237 0.6×	250 0.6×	73	2.7k
Rovshan Khalilov Azerbaijan	30	832 0.7×	792 0.9×	1.0k 1.2×	177 0.4×	237 0.6×	81	3.0k
Seyed Mahdi Rezayat Iran	38	819 0.7×	1.1k 1.3×	1.0k 1.2×	185 0.4×	346 0.8×	169	4.0k
Ramar Thangam India	35	1.0k 0.8×	953 1.1×	1.1k 1.3×	221 0.5×	497 1.2×	74	3.7k
Abbas Pardakhty Iran	38	582 0.5×	1.6k 1.7×	611 0.7×	430 1.0×	195 0.5×	143	4.5k

Countries citing papers authored by Krishnan Anand

Since Specialization

Citations

This map shows the geographic impact of Krishnan Anand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishnan Anand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishnan Anand more than expected).

Fields of papers citing papers by Krishnan Anand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishnan Anand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishnan Anand. The network helps show where Krishnan Anand may publish in the future.

Co-authorship network of co-authors of Krishnan Anand

This figure shows the co-authorship network connecting the top 25 collaborators of Krishnan Anand. A scholar is included among the top collaborators of Krishnan Anand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishnan Anand. Krishnan Anand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gangadaran, Prakash, Ramya Lakshmi Rajendran, Anshika Goenka, et al.. (2025). Noninvasive in vivo imaging of macrophages: understanding tumor microenvironments and delivery of therapeutics. Biomarker Research. 13(1). 20–20. 7 indexed citations

Maharaj, Niren Ray, et al.. (2025). Exosomal‐complement system activation in preeclampsia. Journal of obstetrics and gynaecology research. 51(3). e16255–e16255. 1 indexed citations

Biswas, S B, Prakash Gangadaran, Shreya Ghosh, et al.. (2025). Extracellular Vesicles in Osteogenesis: A Comprehensive Review of Mechanisms and Therapeutic Potential for Bone Regeneration. Current Issues in Molecular Biology. 47(8). 675–675. 1 indexed citations

Mishra, Aswini Kumar, et al.. (2024). Unveiling asymmetric return spillovers with portfolio implications among Indian stock sectors during Covid-19 pandemic. The North American Journal of Economics and Finance. 75. 102297–102297. 1 indexed citations

Adhikari, Manab Deb, et al.. (2024). Landscape of exosomes to modified exosomes: a state of the art in cancer therapy. RSC Advances. 14(42). 30807–30829. 13 indexed citations

Rajendran, Ramya Lakshmi, Sushmita Sen, Chae Moon Hong, et al.. (2024). Exosomes in Bone Cancer: Unveiling their Vital Role in Diagnosis, Prognosis, and Therapeutic Advancements. Journal of Cancer. 15(13). 4128–4142. 3 indexed citations

Rajendran, Ramya Lakshmi, et al.. (2024). Alzheimer’s Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions. International Journal of Molecular Sciences. 25(17). 9690–9690. 5 indexed citations

Maharaj, Niren Ray, et al.. (2024). Role of vertical circulating exosomes biomarkers in preeclampsia. SHILAP Revista de lepidopterología. 4(4). 2 indexed citations

Mukerjee, Nobendu, Sagnik Nag, Αθανάσιος Αλεξίου, et al.. (2024). Clinical impact of epithelial–mesenchymal transition for cancer therapy. SHILAP Revista de lepidopterología. 4(1). 14 indexed citations

10.

Shaikh, Mohammad Arshad Javed, Obaid Afzal, Waleed Hassan Almalki, et al.. (2023). Harnessing chitosan-adorned liposomes for enhanced drug delivery in cancer. Journal of Drug Delivery Science and Technology. 85. 104619–104619. 11 indexed citations

11.

Gorai, Sukhamoy, et al.. (2023). Tear exosomes: A messenger of clinical health complication. SHILAP Revista de lepidopterología. 3(6). 2 indexed citations

12.

Dhar, Rajib, Sukhamoy Gorai, Sagnik Nag, et al.. (2023). Exosomal miRNAs and breast cancer: a complex theranostics interlink with clinical significance. Biomarkers. 28(6). 502–518. 18 indexed citations

13.

Nag, Sagnik, Krishnan Anand, Rajalakshmanan Eswaramoorthy, et al.. (2023). Clinical Theranostics Trademark of Exosome in Glioblastoma Metastasis. ACS Biomaterials Science & Engineering. 9(9). 5205–5221. 17 indexed citations

14.

Nag, Sagnik, Nobendu Mukerjee, Krishnan Anand, et al.. (2023). Role of Exosomes in Epithelial–Mesenchymal Transition. ACS Applied Bio Materials. 7(1). 44–58. 22 indexed citations

15.

Nag, Sagnik, Nobendu Mukerjee, Swastika Maitra, et al.. (2023). Unlocking Exosome-Based Theragnostic Signatures: Deciphering Secrets of Ovarian Cancer Metastasis. ACS Omega. 8(40). 36614–36627. 15 indexed citations

16.

Muthu, Sathish, et al.. (2023). Clinical Theragnostic Signature of Extracellular Vesicles in Traumatic Brain Injury (TBI). ACS Chemical Neuroscience. 14(17). 2981–2994. 11 indexed citations

17.

Chellappan, Dinesh Kumar, Murtaza M. Tambuwala, Alaa A. A. Aljabali, et al.. (2021). Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and In Vitro Drug Release Studies. Assay and Drug Development Technologies. 19(4). 246–261. 9 indexed citations

18.

Ganesan, R., Sinthuran Jegatheeswaran, Balakumar Chandrasekaran, et al.. (2020). Phyto-Engineered Gold Nanoparticles (AuNPs) with Potential Antibacterial, Antioxidant, and Wound Healing Activities Under in vitro and in vivo Conditions. SHILAP Revista de lepidopterología. 2 indexed citations

19.

Boomi, Pandi, G. Poorani, Samayanan Selvam, et al.. (2020). Green biosynthesis of gold nanoparticles using Croton sparsiflorus leaves extract and evaluation of UV protection, antibacterial and anticancer applications. Applied Organometallic Chemistry. 34(5). 49 indexed citations

20.

Ponraj, Thondhi, Raju Vivek, Manickam Paulpandi, et al.. (2018). Mitochondrial dysfunction-induced apoptosis in breast carcinoma cells through a pH-dependent intracellular quercetin NDDS of PVPylated-TiO₂NPs. Journal of Materials Chemistry B. 6(21). 3555–3570. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact